ATLX — Q2 2026 Financial Report Analysis

Atlas Lithium is building a lithium mine in Brazil and doesn't sell lithium yet. Its second quarter of 2026 was about clearing the way to build. On June 29 it received the expansion permit for its Neves Project in Minas Gerais, and in April and May it signed its main engineering and construction contractors. The cost showed up in overhead: the net loss attributable to Atlas Lithium shareholders nearly doubled to $10.2 million (from $5.6 million), driven by a $5.0 million jump in general and administrative (G&A) expenses, mostly lawyers and consultants working on the permit. Cash was $36.1 million at June 30, but $10.0 million of convertible notes come due on November 7, 2026, and the 10-Q discloses no financing yet to pay for building the mine.

At a glance

• Net loss of $10.2 million attributable to shareholders, $0.35 per share (Q2 2025: $5.6 million, $0.31). The loss grew 84%, but the loss per share grew only 13%, because the average share count rose 63% (to 29.4 million from 18.0 million) after a year of stock sales.
• $18.2 million of cash used by operations in the first half (H1 2025: $8.3 million), more than double the year before. Only $2.0 million went into mine assets, down from $6.3 million.
• $36.1 million cash, $10.0 million notes due in November. The notes convert into shares at $28.225 each, far above the roughly $5.18 average price Atlas got selling shares this year, so investors are unlikely to convert. Expect the notes to be repaid in cash or refinanced.

The numbers

Atlas Lithium consolidates Atlas Critical Minerals (Nasdaq: ATCX). It owns only about 20% of ATCX but controls it, so ATCX's results appear in Atlas's statements, which is why the table separates the total loss from the share that belongs to Atlas Lithium shareholders. All revenue comes from ATCX's small quartzite and iron-ore operations (one customer in H1 2026). There is no lithium revenue yet.

Operating margin (operating profit as a share of revenue) isn't meaningful when revenue is zero, so we leave it out. For a company at this stage, the figures to watch are the cash it spends and how long its cash will last.

First half of 2026: net revenue $74k (H1 2025: $57k); G&A $20.3 million (H1 2025: $9.4 million); stock-based compensation $8.1 million ($6.4 million); net loss attributable to Atlas Lithium $23.8 million ($14.6 million); loss per share $0.84 in both years, because the share count grew as fast as the loss.

Where the money went

The 10-Q explains the G&A increase as "(i) higher payroll expenses due to the increasing operational activities related to project implementation; and (ii) a $4.2 million increase in third-party service costs, including legal consultants, incurred to support the completion of the environmental permitting process and preliminary project implementation activities." Over the half-year, third-party service costs were up $7.9 million. The half also included a larger bonus paid to the CEO under his employment agreement.

Stock-based compensation is pay or fees settled in shares instead of cash. It rose $0.5 million in the quarter, mainly because Atlas issued 196,839 shares worth $1.0 million to Mitsui & Co., which is already a shareholder. The shares paid for advisory work on "financing efforts and strategic government initiatives for the Neves Project," under a January 2026 memorandum of understanding. Mitsui also holds an offtake agreement (a contract to buy future output) for up to 60,000 dry tonnes of concentrate a year, up to 300,000 tonnes in total.

Spending on the mine itself fell. In the first half Atlas paid $1.8 million for capital assets (H1 2025: $4.7 million). The 2025 figure included the one-time cost of shipping the processing plant from South Africa to Brazil. Capitalized exploration and development costs, meaning drilling and site work recorded as an asset instead of an expense, fell to $0.2 million from $1.6 million because of "the reduction in the development activities in 2026." The processing plant is already paid for and is recorded as $30.4 million of construction-in-progress. The company says it is "ready for assembly."

Net finance income helped a little: +$0.32 million in the quarter, versus a $0.18 million cost a year earlier. The gain came from interest on the larger cash balance and from currency hedges (contracts that lock in an exchange rate) that settled at a profit as the Brazilian real strengthened.

What the headline numbers hide

• Cash came from selling shares, not from the business. Cash rose only $0.16 million in the first half. About $20.3 million was spent on operations and investment. That was replaced by $11.3 million from selling 2.19 million Atlas shares through an at-the-market program (selling new shares gradually on the open market) and $9.6 million from ATCX's January IPO and Nasdaq listing. Shareholders who don't buy in are diluted: shares outstanding rose to 30.06 million at June 30 from 26.97 million at December 31.
• Some of the $36.1 million belongs to ATCX. ATCX's IPO proceeds are "being used to advance exploration and development activities on Atlas Critical Minerals' mineral properties." Atlas owns only about 20% of ATCX, and minority shareholders' equity in the balance sheet jumped to $6.3 million from $0.6 million. The 10-Q doesn't say how much of the consolidated cash sits inside ATCX, but that portion isn't freely available to build Neves. (Our ATCX H1 2026 report covers that company separately.)
• The cash runway is shorter than the headline suggests. Management states that cash "will be sufficient to meet our working capital and capital expenditure requirements for a period of at least twelve months." There is no going-concern warning (an auditor's or management's statement that the company may not survive the next year). But the 10-Q also warns that if financing isn't available, the company "may be forced to scale back" and that this "could raise substantial doubt about our ability to continue as a going concern." The arithmetic is tight. Take $36.1 million, subtract the $10.0 million of notes due November 7, and about $26 million remains. That's roughly 7–8 months of first-half spending (about $3.4 million a month) before any mine construction starts. Some of the first-half costs were one-offs tied to the permit, so the monthly rate could ease. Building the mine would push it the other way.
• Other liabilities. The balance sheet carries a $20.0 million "deferred consideration from royalties sold." This is a 2023 deal in which Lithium Royalty Corp. paid $20 million upfront for 3% of future gross revenue from the Neves area. It isn't a loan to repay in cash, but it permanently reduces what Atlas keeps from each sale. Outstanding purchase commitments for the processing plant are small, at $0.5 million.
• An accounting change. From January 1, 2026 the Brazilian subsidiaries switched their accounting currency from the real to the U.S. dollar. ATCX's U.S. listing was the trigger. Currency moves now pass through the income statement differently than in 2025, so year-over-year foreign-exchange lines aren't fully comparable. The amounts involved are small.

Takeaway: The second quarter turned Neves from a permitting story into a construction-funding story. With the expansion permit, the contractors signed and the plant already on site, the obstacle left is money. Atlas has about $26 million after repaying the November notes, it is spending about $3.4 million a month before construction begins, and the 10-Q discloses no project loan or prepayment deal. How Atlas finances the build matters more to shareholders than any quarterly loss figure: through debt, offtake prepayments from buyers like Mitsui, or more share sales that dilute existing holders.

What's next

What management says. The 10-Q gives no production date and no updated construction budget. It says each contract awarded so far, with Promon Engenharia (engineering), TSX Engineering (project management), Cerne Construções (facilities, under an EPC contract where one firm handles engineering, procurement and construction), RETC Infraestrutura (earthworks) and Alfa Engenharia (plant assembly), was "finalized at or below the budget projections" in the Definitive Feasibility Study (DFS, the detailed engineering and cost study for the mine). The company also says it "received written indications of interest from several parties seeking to secure long-term supply arrangements." Neves was the only Brazilian lithium project named in the March 2026 Japan–U.S. critical-minerals cooperation fact sheet. The amended 2025 annual report (10-K/A, filed August 14) reclassified Atlas from an exploration-stage company to a development-stage one. It reports proven reserves of 7.25 million tonnes of ore at 1.23% lithium oxide, enough for about 951,000 tonnes of spodumene concentrate (the lithium-rich mineral product sold to battery-chemical makers). That estimate assumes a price of $1,700 per tonne for concentrate at 5.5% lithium oxide.

Our view. Three things will decide Atlas's next six months:

1. How the $10.0 million notes due November 7 are handled: repaid in cash, extended, or swapped for new securities.
2. Whether a construction financing package is announced. A debt facility or an offtake prepayment would cost existing shareholders less than more share sales.
3. Whether G&A falls back toward the 2025 level now that permitting is done. If quarterly G&A stays near $9–10 million while construction spending begins, the company will need to raise money in early 2027.

The project's milestones are real, but a lower-risk equity story needs funding, not permits.

This is our first report on Atlas Lithium, so there is no earlier outlook to check against.